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Respiratory tract infections among 
French Hajj pilgrims from 2014 to 
2017
Van-thuan Hoang1,2,3, Saliha Ali-Salem1,2, Khadidja Belhouchat1,2, Mohammed Meftah1,2, 
Doudou Sow1,2,4, Thi-Loi Dao1,2,3, Tran Duc Anh Ly1,2, Tassadit Drali1,2, Laetitia ninove5, 
Saber Yezli6, Badriah Alotaibi6, Didier Raoult2,7, Philippe parola1,2, Vincent pommier de Santi1,2,8 
& philippe Gautret1,2*
Respiratory tract infections (RTIs) are common among Hajj pilgrims, but risk factors for RTIs and 
respiratory pathogen acquisition during the Hajj are not clearly identified. Based on previous studies, 
most frequent pathogens acquired by Hajj pilgrims were investigated: rhinovirus, human coronaviruses, 
influenza viruses, Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and 
Haemophilus influenzae. 485 pilgrims were included. 82.1% presented with RTIs. Respiratory chronic 
diseases were associated with cough, Influenza-like illness (ILI) and the acquisition of H. influenzae. 
Vaccination against invasive pneumococcal diseases (IPD) and influenza was associated with a decrease 
in the acquisition of S. pneumoniae and prevalence of ILI (aRR = 0.53, 95%CI [0.39–0.73] and aRR = 0.69, 
95%CI [0.52–0.92] respectively). Individuals carrying rhinovirus and H. influenzae-S. pneumoniae 
together were respectively twice and five times more likely to have respiratory symptoms. Individual 
with H. influenzae-K. pneumoniae carriage were twice (p = 0.04) as likely to develop a cough. The use 
of disposable handkerchiefs was associated with a decrease in the acquisition of S. aureus (aRR = 0.75, 
95%CI [0.57–0.97]). Results could be used to identify pilgrims at increased risk of RTIs and acquisition 
of respiratory pathogens. Results also confirm the effectiveness of influenza and IPD vaccinations in 
reducing ILI symptoms and acquisition of S. pneumoniae carriage respectively.
The Hajj is one of the largest annual religious mass gatherings in the world. Each year, Saudi Arabia attracts over 
2 million pilgrims from over 180 countries, including about 2,000 from Marseille, France1. The Hajj presents 
major challenges in public health and infection control as the crowding conditions favor the acquisition, dissem-
ination and transmission of pathogenic microorganisms2. Respiratory tract infections (RTIs) are particularly 
frequent during the pilgrimage and are responsible for most causes of hospitalization, with community-acquired 
pneumonia being a major cause of serious illness among pilgrims3. Many studies have been conducted among 
Hajj pilgrims over the last decade, demonstrating the high prevalence of respiratory symptoms and the frequent 
acquisition of respiratory pathogens3–7. The viruses most commonly acquired after the Hajj are human rhinovirus 
(HRV), human coronaviruses (HCoV) and influenza A virus (IAV). The most frequently acquired respiratory 
bacteria are Streptococcus pneumoniae (S. pneumoniae), Staphylococcus aureus (S. aureus) and Haemophilus influ-
enzae (H. influenzae)3. However, the etiology of RTIs at the Hajj is likely multifactorial and complex. The poten-
tial effects of vaccination against influenza and pneumococcus8,9, of non-pharmaceutical preventive measures 
including face-mask use and hand hygiene practice10–12 have been investigated, mostly based on clinical criteria, 
but results of studies are contradictory.
So far, to our knowledge, risk factors for pathogen acquisition during the Hajj are not clearly identified. 
Relationship between respiratory symptoms and carriage of respiratory pathogens at the Hajj also remain 
poorly understood making it difficult distinguishing between infection and colonization. We conducted this 
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study to identify risk factors for respiratory symptoms and respiratory pathogens carriage at the Hajj, including 
socio-demographics, vaccination against influenza and invasive pneumococcal diseases (IPD) and adherence to 
non-pharmaceutical preventive measures using data collected from 2014 to 2017. We also evaluated the relation-
ship between pathogen carriage, including multiple carriage and respiratory symptoms.
Results
Characteristics of study participants. The study enrolled 485 pilgrims, 96.5% of whom filled both the 
pre- and post-travel questionnaires. The study population had a median age of 61.5 years (interquartile = (52 – 68 
years), min = 21, max = 96 years) and a male:female ratio of 1:1.3 (Table 1). The majority (88.4%) of the pilgrims 
were from North Africa. 66.3% had an indication for vaccination against IPD according to the French recom-
mendation at the time of inclusion13–20. Diabetes (28.6%) and hypertension (29.5%) were the most common 
comorbidities (Table 1).
With regard to preventive measures, 96 (20.2%) pilgrims reported having been vaccinated against pneumo-
coccal (PCV-13) in the last 5 years, representing 30.5% of pilgrims with an indication for IPD. 26.7% (127/466) 
were vaccinated against influenza before their travel or in the past year. Two hundred sixty-one (56.0%) pilgrims 
reported using face masks during the Hajj. Also, 42.1% (196/466), 50.4% (235/466) and 73.6% (343/466) pilgrims 
declared washing their hands during the Hajj more often than usual, using hand gel, and using disposable hand-
kerchiefs during their stay in Saudi Arabia, respectively.
Clinical features. Figure 1 shows the prevalence of respiratory symptoms among pilgrims during the Hajj. 
More than 80% of the pilgrims presented at least one respiratory symptoms, cough, sore throat and rhinitis being 
the most frequent. Influenza-like illness (ILI) was present in 16.9% of pilgrims. None suffered from pneumonia 
or other IPD, and only one was hospitalized during the 2017 Hajj season. Time between arrival in Saudi Arabia 
and onset of symptoms was 9.5 ± 4.8 days (min = 0, max = 22 days).
Detection of respiratory pathogens by qPCR. Pre- and post-Hajj specimens were collected from 456 
(94.0%) and 451 (93.0%) participants, respectively. Furthermore, 32.6% (125/384) ill pilgrims were sampled at 
onset of respiratory symptoms. At total of 433 (89.3%) pilgrims had paired samples.
The prevalence of respiratory pathogens carriage increased after a participation in Hajj, compared to 
pre-Hajj status, and differences were significant for all bacterial pathogens and all viruses with the exception of 
Variables n %
Pilgrimage year
2014 98 20.2
2015 119 24.6
2016 117 24.1
2017 151 31.1
Gender
Male 212 43.7
Female 273 56.3
Age*
Median 61.5
Interquartile 52–68
Min - max 21–96
Age ≥ 60 years* 269 56.0
Place of birth
France 40 8.5
North Africa 419 88.4
Sub-Saharan Africa 13 2.7
Others 2 0.4
Comorbidities*
Diabetes mellitus 136 28.6
Hypertension 140 29.5
Chronic respiratory disease 56 11.8
Chronic heart disease 32 6.7
Chronic kidney disease 5 1.1
Immunodefiency 3 0.6
Indication for vaccination against IPD1 315 66.3
BMI2
Normal 130 26.8
Underweight 3 0.6
Overweight 220 45.4
Obesity 132 27.2
Table 1. Characteristics of the study population, Hajj pilgrims 2014-2017 (N = 485). 1Indication for vaccination 
against invasive pneumococcal diseases: Age superior or equal to 60 years, diabetes mellitus, chronic respiratory 
disease, chronic heart disease, chronic kidney disease and immunodeficiency, (n = 475, 10 missing data). 2Body 
mass index. Normal weight: BMI: 18.5 – 24.9, Underweight: BMI <18.5, Overweight: BMI: 25.0 – 29.9, Obesity: 
BMI ≥30. *n = 480, 5 mission data.
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HCoV-HKU1 (Table 2). Overall, 33.0% of pilgrims acquired at least one respiratory virus, notably RHV (26.9%), 
HCoV (8.0%) and influenza viruses (3.7%). A similar proportion (35.3%) acquired at least one respiratory bacte-
rium after the Hajj, mainly H. influenzae (31.7%), Klebsiella pneumoniae (K. pneumoniae) (20.9%), S. pneumoniae 
(17.9%) and S. aureus (14.0%). Overall, viral-bacterial acquisition proportion in returned Hajjes was 26.9%, the 
most common being H. influenzae-virus dual carriage (Table 2). Among the 125 pilgrims sampled at symptom 
onset, a high prevalence of HRV (47/125, 37.6%), S. aureus (35/125, 28.0%) and H. influenzae (49/125, 39.2%) 
carriage was observed.
To compare between pre- and per-Hajj specimens, 122 ill pilgrims have had paired samples. The acquisition 
proportion of HRV, S. aureus and H. influenzae was 39/122 (32.0%), 14/122 (11.5%) and 43/122 (35.3%) respec-
tively (data not show).
Risk factors for respiratory symptoms. The Supplementary Table 1 and Table 3 show univariate and 
multivariate analyses results for factors associated with respiratory symptoms during the Hajj. Reporting of at 
least one respiratory symptom was twice as frequent and five times more frequent in rhinovirus carriers (adjusted 
relative risk (aRR): 1.98, 95%CI [1.03–3.78]) or H. influenzae-S. pneumoniae carriers, respectively (aRR: 4.75, 
95%CI [1.17–19.35]) (Table 3). Coughing was twice as frequent in pilgrims suffering from chronic respira-
tory disease and among those carrying H. influenzae-K. pneumoniae together (aRR: 1.98, 95%CI [1.03–3.78]). 
Pilgrims who coughed were also more likely to use disposable handkerchiefs. Finally, ILI was more frequent in 
females, in pilgrims with chronic respiratory disease and among those carrying S. aureus or an association of 
virus and bacteria. In addition, pilgrims suffering ILI were more likely to use face mask. Influenza virus was not 
significantly associated with ILI. No significant association was observed between symptoms and vaccination 
against IPD. However, influenza vaccination was associated with a decrease in the prevalence of ILI (aRR: 0.69, 
95%CI [0.52–0.92]).
We found no significant association between persistence of respiratory symptoms at return and pathogen car-
riage with the exception of H. influenzae carriage in association with viral carriage (aRR: 1.65, 95%CI [1.07–2.53], 
p = 0.02).
Risk factors for respiratory pathogens acquisition among pilgrims. The Supplementary Tables 2 
and 3 show the univariate risk factors analysis for respiratory virus and bacteria acquisition, respectively. In mul-
tivariate analysis (Table 4), male gender was associated with decreased acquisition of HCoV and K. pneumoniae 
(aRR: 0.76, 95%CI [0.58–0.99]). Older age (≥60 years) was associated with an increased acquisition of influenza 
viruses, HCoV and S. pneumoniae (aRR: 1.39, 95%CI [1.01–1.93], aRR: 1.53, 95%CI [1.16–2.01] and aRR: 1.28, 
95%CI [1.01–1.63] respectively). Chronic respiratory disease was associated with increased acquisition of H. 
influenzae (aRR: 1.69, 95%CI [1.14–2.50]). No effect of vaccination against influenza was found. By contrast, 
vaccination against IPD was associated with a decrease in the acquisition of S. pneumoniae (aRR: 0.53, 95%CI 
[0.39–0.73]). Of note, IPD vaccination did not significantly influenced S. pneumoniae carriage at baseline (in 
pre-Hajj samples) (RR: 0.47, 95%CI [0.11–1.99], p = 0.29). Acquisition of HRV was higher among pilgrims who 
reported using facemasks (aRR = 1.30, 95%CI [1.03–1.65]). The use of disposable handkerchiefs has been associ-
ated with a decrease in the acquisition of S. aureus (aRR: 0.75, 95%CI [0.57–0.97]). Hand hygiene and the use of 
a disinfectant gel do not have a significant effect on the acquisition of pathogens.
Discussion
Our results confirm that respiratory infections were very common among French Hajj pilgrims, with more than 
80% of them reporting at least one symptom during the 2014–2017 Hajj seasons. Our result is in line with the 
previous results obtained from cohort studies conducted among French pilgrims21 and from a large cohort study 
enrolling pilgrims from 13 different countries22. We also document the significant acquisition of almost all viral 
and bacterial pathogens included in our survey, following participation to the Hajj, as reported previously3,23.
We found that male gender was independently associated with a decreased risk for ILI and for the acquisition 
of coronaviruses and K. pneumoniae. We have no explanation for this unexpected observation. Older age (≥60 
Figure 1. Prevalence of respiratory symptoms among pilgrims during the Hajj 2014–2017.
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years) was associated with the acquisition of influenza viruses, HCoV and S. pneumoniae. Although older age 
was not correlated with the increase in the proportion of respiratory symptoms in our study, our results support 
the current French recommendations that indicate influenza vaccination for all pilgrims and IPD vaccination for 
pilgrims aged ≥60 years old (or with chronic conditions)24,25. Furthermore, we showed that influenza vaccination 
was significantly associated with a lower prevalence of ILI in our survey. Similarly, in a meta-analysis, Alfelali et 
al. have shown that, influenza vaccine decreases the prevalence of ILI26. We also demonstrate here that vaccina-
tion against IPD with a decrease in the acquisition of S. pneumoniae, but had no effect on respiratory symptoms. 
A protective effect of pneumococcal vaccination against S. pneumoniae post-Hajj carriage was observed in only 
one out of 5 studies so far9. However, all studies showing no effect of pneumococcal vaccination were conducted 
on small groups of pilgrims (ranging 55 to 107 individuals), while in the two studies showing a protective effect, 
the number of pilgrims was much higher (1178 and 468) which may indicate that small surveys lacked statistical 
power. Finally, as expected, patients suffering from chronic respiratory diseases were more likely to suffer from 
cough and ILI but also to acquire H. influenzae. Our results confirm the need for influenza and IPD vaccination 
among the identified pilgrim populations at risk of RTIs and acquisition of respiratory pathogens. Vaccination 
rates in our cohort were clearly sub-optimal: 26.7% of pilgrims were vaccinated against influenza and 30.5% 
against IPD among those with an indication.
With regard to non-pharmaceutical preventive measures, the use of masks, especially in crowded areas, fre-
quent hand washing with water and soap or disinfectant, especially after coughing and sneezing, and the use of 
disposable handkerchiefs are recommended by the Saudi Ministry of Health to Hajj pilgrims27. In a meta-analysis 
including 13 surveys of Hajj pilgrims, significant protection of face masks was found against RITs, but the end 
points varied considerably12. We found that there was a higher prevalence of ILI and rhinovirus acquisition 
among pilgrims who reported wearing face masks. Similarly, a higher prevalence of cough was observed among 
pilgrims who reported using disposable handkerchiefs. It is likely that such results indicate the higher willing-
ness of symptomatic pilgrims to wear a face mask and use disposable handkerchiefs, with the aim of avoiding 
spreading diseases. In addition, the use of disposable handkerchiefs appears to be correlated with a decrease in the 
Pathogens
Pre-Hajj Per-Hajj Post-Hajj Acquisition
p*n = 456 % n = 125 % n = 451 % n %
Viruses
       At least one virus 20 4.4 54 43.2 147 32.6 147 33.9 <10−4
       All influenza viruses 0 0 6 4.8 11 2.4 16 3.7 <10−4
       Influenza A 0 0 5 4.0 8 1.8 12 2.8 5.10−4
       Influenza B 0 0 1 0.8 3 0.7 4 0.9 0.05
       Rhinovirus 18 4.0 47 37.6 117 25.9 120 27.7 <10−4
       All coronaviruses 2 0.4 17 13.6 29 6.4 36 8.3 <10−4
       Coronavirus 229E 2 0.4 11 8.8 20 4.4 27 6.2 <10−4
       Coronavirus HKU1 0 0 1 0.8 1 0.2 1 0.2 0.31
       Coronavirus NL63 0 0 3 2.4 5 1.1 6 1.4 0.01
       Coronavirus OC43 0 0 4 3.2 3 0.7 6 1.4 0.01
Bacteria
       At least one bacterium 217 47.6 78 62.4 344 76.3 159 36.7 <10−4
       S. aureus 68 14.9 35 28.0 97 21.5 63 14.5 3.10−3
       S. pneumoniae 18 4.0 5 4.0 89 19.7 80 18.5 <10−4
       H. influenzae 127 27.9 49 39.2 232 51.4 144 33.3 <10−4
       K. pneumoniae 58 12.7 15 12.0 115 25.5 94 21.7 <10−4
Bacteria co-infections
       H. influenzae-S. pneumoniae 9 2.0 2 1.6 49 10.9 47 10.9 <10−4
       H. influenzae-K. pneumoniae 30 6.6 6 4.8 63 14.0 62 14.3 <10−4
       H. influenzae-S. aureus 8 1.8 14 11.2 47 10.4 52 12.0 <10−4
       S. pneumoniae-K. pneumoniae 4 0.9 1 0.8 23 5.1 24 5.5 2.10−4
       S. pneumoniae-S. aureus 1 0.2 2 1.6 21 4.7 22 5.1 <10−4
       K. pneumoniae-S. aureus 6 1.3 4 3.2 21 4.7 23 5.3 3.10−4
Bacteria-virus co-infections
       At least one virus-bacteria combinaison 6 1.32 29 23.2 113 25.1 120 27.7 <10−4
       S. pneumoniae-virus 1 0.2 2 1.6 37 8.2 37 8.5 <10−4
       K. pneumoniae-virus 1 0.2 8 6.4 34 7.5 41 9.5 <10−4
       S. aureus-virus 2 0.4 13 10.4 36 8.0 39 9.0 <10−4
       H. influenzae-virus 4 0.9 16 12.8 76 16.9 83 19.3 <10−4
Table 2. Acquisition of respiratory pathogens during the Hajj. *p value: pre-Hajj versus per-Hajj and/or post-
Hajj, McNemar’s Test.
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acquisition of S. aureus carriage, which may reflect a better elimination of organisms by cleaning the nasophar-
ynx. We found that increased hand hygiene was not associated with reduced respiratory pathogens acquisition 
or a lower prevalence of respiratory symptoms. In a recent review paper, it was shown that while hand hygiene 
using non-alcoholic products was generally well accepted by Hajj pilgrims, there was no conclusive evidence of 
its effectiveness, which is consistent with our results11.
Relationship between respiratory symptoms and carriage of respiratory pathogens at the Hajj are unclear. 
Because of the high frequency of respiratory symptoms, the distinction between infection and colonization 
is difficult to assess. Furthermore, asymptomatic carriage of potential pathogens is also observed among Hajj 
pilgrims28. Nevertheless, in the final model of multivariate analysis, the acquisition of S. aureus was associated 
with ILI and the acquisition of rhinovirus was associated with respiratory symptoms. Many studies showed 
that S. aureus and rhinovirus were among the predominant pathogens isolated from the Hajj pilgrims suffering 
RTIs9,11,12,21,23–32. Most cases of infections due to HRV are benign, self-limited cold-like illnesses. Nevertheless, 
HRV is also responsible for severe pneumonia in the elderly and immunocompromised patients, as well as exac-
erbations of chronic obstructive pulmonary disease and asthma33. HRV spreads mostly via direct contact or 
contact with a fomite, with inoculation to the eye or nose from fingertips34. The human-to-human transmission 
of rhinovirus among pilgrims may have been favored by the crowded conditions at pilgrim accommodations or 
during performing the Hajj rites.
S. aureus is also often part of the human microbiome in the anterior nares35. However, persistent S. aureus 
nasal carriage is associated with secondary staphylococcal respiratory infection, predisposing to invasive dis-
ease, especially in the case of detection of IAV36–38. To date, few studies addressed virus-bacteria carriage in 
relation with RTIs at the Hajj4,28. In our study, overall carrying virus-bacteria was associated with ILI. Dual H. 
influenzae-K. pneumoniae carriage was associated with twice the risk of coughing and H. influenzae-S. pneumo-
niae carriage with 5 times the risk for respiratory symptoms. Further works aiming at better understanding the 
role of overall carrying virus and bacteria in the pathogenesis of the RTIs at the Hajj are needed.
Our study had some limitations. The study was conducted among French pilgrims only and cannot be general-
ized to all pilgrims. Observance with individual preventive measures was self-reported and frequency of changing 
Variables
Cough ILI† At least one symptom
aRR [95%CI] p aRR [95%CI] p aRR [95%CI] p
       Male gender — 0.75 [0.58–0.96] 0.02 —
       Chronic respiratory disease 2.24 [1.04–4.82] 0.04 1.47 [1.01–2.16] 0.05 —
Prevention measures
       Mask — 1.42 [1.10–1.82] 0.007 —
       Disposable handkerchiefs 1.71[1.17–2.50] 0.006 — —
       Vaccination against influenza — 0.69 [0.52–0.92] 0.012 —
Pathogens carriage during the Hajj
       Human rhinovirus — — 2.03 [1.14–3.61] 0.02
       S. aureus — 1.34 [1.01–1.82] 0.044 —
       H. influenzae – K. pneumoniae 1.98 [1.03–3.78] 0.04 —
       H. influenzae – S. pneumoniae — — 4.75 [1.17–19.35] 0.03
       At least one virus-bacteria combinaison — 1.33 [1.01–1.74] 0.04 —
Table 3. Risk factor for respiratory symptoms during the Hajj (multivariate analysis). †ILI: influenza-like illness. 
aRR: adjusted relative risk, CI: confidence interval, p: p value.
Variables
Influenza viruses Human rhinovirus Human coronaviruses S. aureus S. pneumoniae H. influenzae K. pneumoniae
aRR [95%CI] p aRR [95%CI] p aRR [95%CI] p aRR [95%CI] p aRR [95%CI] p aRR [95%CI] p aRR [95%CI] p
Socio-demographics characteristic
       Male gender 0.76 [0.58  – 0.99] 0.05
0.78 [0.62 – 
0.98] 0.04
       Age ≥60 years 1.39 [1.01 –  1.93] 0.04
1.53 [1.16  
– 2.01] 0.003
1.28 [1.01  – 
 1.63] 0.05
       Chronic respiratory disease 1.69 [1.14 – 2.50] 0.01
Preventive measures
Vaccination against IPD 0.53 [0.39 –  0.73] < 0.0001
Mask 1.30 [1.03 –  1.65] 0.03
Handkerchief 0.75 [0.57  – 0.97] 0.03
Table 4. Risk factor for acquisition of respiratory pathogens during the Hajj (multivariate analysis). aRR: 
adjusted relative risk, CI: confidence interval, p: p value, IPD: invasive pneumococcal diseases.
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face mask and exact quantification of hand hygiene practice were not assessed. qPCR used to detect respiratory 
pathogens does not distinguish between dead and living micro-organisms. S. pneumoniae serotypes were not 
investigated. Moraxella catarrhalis that was recently shown to be relatively frequently acquired by Hajj pilgrims39 
was not included in our study. Finally, we did not to be any long-term follow-up to determine what infections 
might have had delayed presentation after return from the pilgrimage. Nevertheless, our study included a large 
samples size of pilgrims spanning four Hajj seasons giving it a stronger statistical power. A number of risk factors 
have been identified to recognize pilgrims at increased risk of RTIs and of acquisition of most common respira-
tory pathogens encountered in this setting. Also, the study confirmed the effectiveness of vaccination against 
influenza in reducing ILI symptoms and that of vaccination against IPD in reducing acquisition of S. pneumoniae. 
Given the limitations of the current study, the use of face mask and a reinforced hand hygiene should still be rec-
ommended for Hajj pilgrims until large-scale controlled studies are conducted to truly assess the effectiveness of 
these measures in the context of Hajj. The use of disposable handkerchief is, de facto, highly frequent among ill 
pilgrims and at least allows decreasing the acquisition of S. aureus.
Methods
Participants and study design. A convenience sample of pilgrims participating in the Hajj from 2014 
to 2017 was surveyed. Potential adult participants were recruited at a private specialized travel agency from 
Marseille, France, organizing journeys to Mecca, Saudi Arabia and invited to participate in the study. They were 
included and followed-up by a medical bilingual (Arabic and French) doctor who traveled with the group. Upon 
inclusion before departing from France, the pilgrims were interviewed using a standardized pre-Hajj question-
naire that collected items about demographic characteristics (age, sex, place of birth), immunization status 
(vaccination against influenza and IPD) and medical history (chronic medical conditions, immunodeficiency, 
body mass index (BMI)). Pilgrims were considered to have been vaccinated immunized against influenza when 
they had been vaccinated within the last year, but before 10 days of the date of travel. Pilgrims were considered 
immune to IPD when they had been vaccinated with the 13-valent conjugate pneumococcal vaccine (PCV-13) 
in the past 5 years13–20. Clinical events occurring during the travel (type of respiratory symptoms, date of onset, 
duration of symptoms, antibiotic treatment provided) and persistence of respiratory symptoms at return were 
collected by a medical doctor using a post-Hajj questionnaire at 2 days before the pilgrims’ return to France. The 
information on compliance with face masks use as well as hand washing, use of hand gel disinfectant and dispos-
able handkerchiefs was documented. Ill pilgrims, who spontaneously consulted the accompanying medical doc-
tor at the time of onset during the Hajj, underwent a complementary nasopharyngeal swab (per-Hajj specimens). 
ILI was defined as the presence of cough, sore throat and subjective fever40. Based on the WHO classification, 
underweight was define as a BMI below 18.5, normal with a BMI from 18.5 to less than 25, overweight with a BMI 
greater ≥25 and obesity with a BMI greater ≥3041.
The protocol was approved by the Aix-Marseille University institutional review board (July 23rd, 2013; refer-
ence no. 2013-A00961-44). The study was performed according to the good clinical practices recommended by 
the Declaration of Helsinki and its amendments. All participants provided an informed written consent.
Respiratory specimen. Nasopharyngeal swabs were obtained from each pilgrim, transferred to 
Sigma-Virocult® medium and stored at −80 °C until processing. Pre-Hajj and post-Hajj nasopharyngeal swabs 
were systematically collected at enrollment, prior traveling to Saudi Arabia and two days prior returning to 
France, respectively. In addition, nasopharyngeal swabs were collected at symptom onset when possible.
Respiratory specimens. DNA and RNA were extracted from the respiratory samples using the EZ1 Advanced XL 
(Qiagen, Hilden, German) with the Virus Mini Kit v2.0 (Qiagen) according to the manufacturer’s recommenda-
tions. Quantitative real-time PCRs were conducted using a C1000 Touch™ Thermal Cycle (Bio-Rad, Hercules, 
CA, USA). Negative control (PCR mix) and positive control (DNA from bacterial strain or RNA from viral strain) 
were included in each run. Positive results of bacteria or virus amplification were defined as those with a cycle 
threshold (CT) value ≤35.
Identification of respiratory virus. One-step duplex quantitative RT-PCR amplifications of HCoV/HPIV-R Gene 
Kit (REF: 71–045, Biomérieux, Marcy l’Etoile, France) was used to detect HCoV and human para-influenza 
viruses according to the manufacturer’s recommendations. One-step simplex real-time quantitative RT-PCR 
amplifications were performed using the Multiplex RNA Virus Master Kit (Roche Diagnostics, France) for HRV, 
IAV, influenza B and internal controls MS2 phage42.
Identification of respiratory bacteria. Real-time PCR amplifications were carried out using the LightCycler® 480 
Probes Master kit (Roche diagnostics, France) according to the recommendations of the manufacturer. The SDD 
gene of H. influenzae, nucA gene of S. aureus, phoE gene of Klebsiella pneumoniae, lytA CDC gene of S. pneumo-
niae, were amplified with internal DNA extraction controls TISS, as previously described22.
The respiratory viruses and bacteria tested in this study were the most frequent microorganism detected 
among French pilgrims, according to previous studies28,29. All other pathogens (adenovirus, bocavirus, metap-
neumovirus, respiratory syncytial virus, parainfluenza viruses, Bordetella pertussis, Mycoplasma pneumoniae, 
Neisseria meningitidis) with prevalence <1% were not included in this study.
The acquisition of respiratory bacteria and viruses was defined as negative before travel and positive during 
the Hajj and/or when returning to France.
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Statistical analysis. STATA software version 11.1 (Copyright 2009 StataCorp LP, http://www.stata.com) was 
used for statistical analysis. Differences in the proportions were tested by Pearson’s chi-square or Fisher’s exact 
tests when appropriate. In order to evaluate the potential acquisition of respiratory pathogens in Saudi Arabia, we 
used the McNemar’s Test to compare their prevalence before leaving France and in Saudi Arabia (during and after 
the Hajj). Unadjusted associations between multiple factors and prevalence of respiratory pathogen acquisition 
and prevalence of respiratory symptom during the Hajj were examined by univariable analysis. The results were 
presented by percentages and risk ratio with 95% confidence interval (95%CI). Results with a p value ≤0.05 was 
considered statistically significant. Only the variables with a prevalence ≥5.0% were considered for statistical 
analysis. Variables with p values <0.2 in the univariable analysis were included in the multivariable analysis. 
Log-binomial regression was used to estimate factor’s adjusted risk ratios regarding respiratory symptoms and 
respiratory pathogens acquisition43.
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